Not available
Quote | Avid Bioservices Inc. (NASDAQ:CDMO)
Last: | $7.54 |
---|---|
Change Percent: | 12.54% |
Open: | $6.7 |
Close: | $6.70 |
High: | $7.72 |
Low: | $6.61 |
Volume: | 517,751 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Avid Bioservices Inc. (NASDAQ:CDMO)
2024-07-03 00:43:35 ET More on Avid Bioservices Avid Bioservices: A Unique Growth Story With Many Tailwinds And Catalysts Avid Bioservices misses top-line and bottom-line estimates; reaffirms FY24 outlook Read the full article on Seeking Alpha For further det...
2024-07-02 19:09:01 ET Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Conference Call July 02, 2024 04:30 PM ET Company Participants Tim Brons - IR, Vida Strategic Partners Nick Green - President & CEO Dan Hart - CFO Matt Kwietniak - Chief Commercial Offi...
Message Board Posts | Avid Bioservices Inc. (NASDAQ:CDMO)
Subject | By | Source | When |
---|---|---|---|
Buy 909K sell 558K | cheynew | investorshub | 06/22/2023 6:02:29 PM |
I guess this works for upcoming options awards. | cheynew | investorshub | 06/22/2023 2:23:05 PM |
Buyvolume 255K sell volume 125K. | cheynew | investorshub | 06/22/2023 2:09:33 PM |
Certainly, the strangest earnings call since Avid has | peregr | investorshub | 06/22/2023 2:01:34 PM |
Flat sales based on what? :: Significant increased | bfiest | investorshub | 06/22/2023 1:48:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
12.54%Change Percent:
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditur...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announc...